Oritavancin for Treatment of Osteomyelitis: A Systematic Review and Meta‐Analysis of Observational Studies
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | Martin Krsak, David Klimpl, Scott W. Mueller, Taylor Morrisette, Alyssa A. Grimshaw, Daniel Chastain, Taylor Steuber, Ranjit Sah, Andres F. Henao‐Martinez, Kyle C. Molina |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM
par: Dana J. Holger, et autres
Publié: (2024)
par: Dana J. Holger, et autres
Publié: (2024)
Biological Therapy and Small Molecules for Adults With Crohn's Disease: Systematic Review and Network Meta‐Analysis
par: Daniela Gorski, et autres
Publié: (2025)
par: Daniela Gorski, et autres
Publié: (2025)
SGLT2 Inhibitors and GLP‐1 Receptor Agonists After Acute Kidney Injury: A Systematic Review With Meta‐Analysis
par: Erin F. Barreto, et autres
Publié: (2026)
par: Erin F. Barreto, et autres
Publié: (2026)
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects
par: Shawn Flanagan, et autres
Publié: (2024)
par: Shawn Flanagan, et autres
Publié: (2024)
Beyond Monotherapy: The Superior Efficacy of Combined GLP ‐1 Receptor Agonist and SGLT2 Inhibitors on Renal Biomarkers: A Systematic Review and Meta‐Analysis
par: Aya M. AbdelMagid, et autres
Publié: (2026)
par: Aya M. AbdelMagid, et autres
Publié: (2026)
Thromboembolic Risk of Thrombopoietin Receptor Agonists for Adult Primary Immune Thrombocytopenia: A Systematic Review and Meta‐Analysis Integrating Randomized Controlled Trials and Prospective Evidence
par: Meng‐Fei Dai, et autres
Publié: (2025)
par: Meng‐Fei Dai, et autres
Publié: (2025)
Cancer Treatment Modalities and Female Fertility Preservation
par: Seonga Song, et autres
Publié: (2026)
par: Seonga Song, et autres
Publié: (2026)
Intravenous Regular Insulin for Treatment of Hyperkalemia in Overweight Patients
par: Denise Kelley, et autres
Publié: (2025)
par: Denise Kelley, et autres
Publié: (2025)
Severe Persistent Urinary Retention Following Treatment With Intravenous Lecanemab
par: Amber N. Navarra, et autres
Publié: (2025)
par: Amber N. Navarra, et autres
Publié: (2025)
Lithium Augmentation in Treatment‐Resistant Depression: A Qualitative Review of the Literature
par: Angela Acero‐González, et autres
Publié: (2025)
par: Angela Acero‐González, et autres
Publié: (2025)
Immune Checkpoint Inhibitor Exposure During Pregnancy: A Systematic Review
par: Casey L. Keller, et autres
Publié: (2026)
par: Casey L. Keller, et autres
Publié: (2026)
Lactated Ringer's versus normal saline in the management of acute diabetic ketoacidosis (RINSE‐DKA)
par: Auriene Jamison, et autres
Publié: (2024)
par: Auriene Jamison, et autres
Publié: (2024)
Treatment Adherence to Oral Direct‐Acting Antiviral Agents in Hepatitis C Infection
par: Javeria Khalid, et autres
Publié: (2026)
par: Javeria Khalid, et autres
Publié: (2026)
Constructing a Personalized Treatment Rule for Initial Therapy in Early Parkinson's Disease
par: Zachary P. Brehm, et autres
Publié: (2025)
par: Zachary P. Brehm, et autres
Publié: (2025)
Scoping review of drug dosing recommendations in sustained low‐efficiency dialysis
par: Nicholas R. Nelson, et autres
Publié: (2024)
par: Nicholas R. Nelson, et autres
Publié: (2024)
Pharmacotherapeutic Controversies During Temperature Control After Out‐of‐Hospital Cardiac Arrest: A Semi‐Structured Literature Review
par: Christy Cecil Forehand, et autres
Publié: (2026)
par: Christy Cecil Forehand, et autres
Publié: (2026)
Aspirin Deprescribing Interventions for Primary Prevention: A Systematic Review and Proposed Guidance for Deprescribing
par: Alison Lobkovich, et autres
Publié: (2026)
par: Alison Lobkovich, et autres
Publié: (2026)
Predictors and Clinical Outcomes of Long‐Term Opioid Therapy in Older Adults: A Systematic Review
par: Iftekhar Ahmed, et autres
Publié: (2026)
par: Iftekhar Ahmed, et autres
Publié: (2026)
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy
par: David B. Cluck, et autres
Publié: (2024)
par: David B. Cluck, et autres
Publié: (2024)
Chloride dipstick to rapidly estimate urine sodium during diuresis in acute heart failure
par: Vacha Shah, et autres
Publié: (2025)
par: Vacha Shah, et autres
Publié: (2025)
Effectiveness of Stimulant Treatment in Preventing Fractures and Head Injuries in Patients With Narcolepsy: A Self‐Controlled Case Series Study
par: Yunlong Zheng, et autres
Publié: (2026)
par: Yunlong Zheng, et autres
Publié: (2026)
Oral β‐Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point‐Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and Fluoroquinolones
par: Ashlan J. Kunz Coyne, et autres
Publié: (2026)
par: Ashlan J. Kunz Coyne, et autres
Publié: (2026)
A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial
par: Kathleen A. Stringer, et autres
Publié: (2025)
par: Kathleen A. Stringer, et autres
Publié: (2025)
Trends in the appropriateness of oral antibiotic prescriptions dispensed in the United States from 2010 to 2018
par: Mahek Garg, et autres
Publié: (2024)
par: Mahek Garg, et autres
Publié: (2024)
Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia
par: Rachel D. Harris, et autres
Publié: (2024)
par: Rachel D. Harris, et autres
Publié: (2024)
High‐Throughput Screening for Prescribing Cascades Among Real‐World Angiotensin‐ II Receptor Blockers ( ARBs ) Initiators
par: Asinamai M. Ndai, et autres
Publié: (2025)
par: Asinamai M. Ndai, et autres
Publié: (2025)
Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
par: Alexandre Duong, et autres
Publié: (2024)
par: Alexandre Duong, et autres
Publié: (2024)
Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
par: Maryam Aghakouchakzadeh, et autres
Publié: (2026)
par: Maryam Aghakouchakzadeh, et autres
Publié: (2026)
Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
par: Mohammed Al Musawa, et autres
Publié: (2024)
par: Mohammed Al Musawa, et autres
Publié: (2024)
Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
par: Atif Siddiqui
Publié: (2025)
par: Atif Siddiqui
Publié: (2025)
Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
par: Jiwon Kim, et autres
Publié: (2025)
par: Jiwon Kim, et autres
Publié: (2025)
Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
par: Hua‐Ping Fan, et autres
Publié: (2024)
par: Hua‐Ping Fan, et autres
Publié: (2024)
Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
par: Keith A. Rodvold
Publié: (2026)
par: Keith A. Rodvold
Publié: (2026)
Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
par: Nicolette Centanni, et autres
Publié: (2025)
par: Nicolette Centanni, et autres
Publié: (2025)
Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
par: Yi‐Fan Chien, et autres
Publié: (2025)
par: Yi‐Fan Chien, et autres
Publié: (2025)
Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
par: Amanda Massmann, et autres
Publié: (2025)
par: Amanda Massmann, et autres
Publié: (2025)
In Search of Big Beautiful Biomarkers
par: C. Lindsay DeVane
Publié: (2025)
par: C. Lindsay DeVane
Publié: (2025)
“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
par: Carlos Augusto Espinoza Cobeñas
Publié: (2024)
par: Carlos Augusto Espinoza Cobeñas
Publié: (2024)
Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
par: Lisa T. Hong, et autres
Publié: (2024)
par: Lisa T. Hong, et autres
Publié: (2024)
Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
par: Nihal El Rouby, et autres
Publié: (2025)
par: Nihal El Rouby, et autres
Publié: (2025)
Documents similaires
-
Updates in pulmonary drug‐resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM
par: Dana J. Holger, et autres
Publié: (2024) -
Biological Therapy and Small Molecules for Adults With Crohn's Disease: Systematic Review and Network Meta‐Analysis
par: Daniela Gorski, et autres
Publié: (2025) -
SGLT2 Inhibitors and GLP‐1 Receptor Agonists After Acute Kidney Injury: A Systematic Review With Meta‐Analysis
par: Erin F. Barreto, et autres
Publié: (2026) -
Phase I study of the pharmacokinetics and safety of rezafungin in subjects with moderate/severe hepatic impairment and matched control subjects
par: Shawn Flanagan, et autres
Publié: (2024) -
Beyond Monotherapy: The Superior Efficacy of Combined GLP ‐1 Receptor Agonist and SGLT2 Inhibitors on Renal Biomarkers: A Systematic Review and Meta‐Analysis
par: Aya M. AbdelMagid, et autres
Publié: (2026)